文献速递临床免疫质量管理与危急值

两种自动化粪便钙卫蛋白免疫分析法检测炎症性肠病的分析与诊断性能

Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel disease.
PubMed 文献 · Clin Chem Lab Med · 2017-01-01

本研究纳入229例连续疑似炎症性肠病患者,评估Liaison® Calprotectin和fCAL™ turbo两种自动化粪便钙卫蛋白免疫分析法,并与Bühlmann ELISA比较。两种自动化方法精密度、准确度和总误差良好,与ELISA相关性好但存在比例差异,诊断性能良好,优化截断值并引入灰区可提高验后概率。

要点

  • 两种自动化粪便钙卫蛋白免疫分析法分析性能良好,CVt≤8.1%,偏倚≤6.7%,总误差≤16.4%。
  • 与ELISA相关性好(rs>0.925),但回归分析显示显著比例差异。
  • 优化厂商截断值并引入灰区可显著提高验后概率。

核心结论

  • 新型粪便提取装置方案性能可接受且与粪便称重法相当。
  • Liaison® Calprotectin和fCAL™ turbo自动化分析法检测IBD的分析与诊断性能良好。

研究设计与样本

  • 研究纳入229例连续疑似炎症性肠病患者,评估两种自动化粪便钙卫蛋白免疫分析法并与Bühlmann ELISA比较。

主要发现

  • 所有检测相关粪便提取程序与既定方法相关性极好,但新提取装置结果倾向于高于粪便称重法。
  • 两种自动化方法精密度(CVt≤8.1%)、准确度(偏倚≤6.7%)和总误差(≤16.4%)表现良好。
  • 与ELISA方法比较相关性好(rs>0.925),但回归分析显示显著比例差异。
  • 诊断IBD的性能良好,与其他报道一致。
  • 优化厂商截断值并引入灰区可显著提高验后概率。

关键数值与推荐

  • 精密度CVt≤8.1%,准确度偏倚≤6.7%,总误差≤16.4%。
  • 与ELISA相关性rs>0.925,但存在显著比例差异。

临床怎么用

  • 两种自动化粪便钙卫蛋白免疫分析法可用于疑似IBD的检测,但需注意与ELISA的比例差异。
  • 优化截断值并引入灰区可能提高诊断验后概率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We evaluated the (pre-)analytical and diagnostic performance of two automated fecal calprotectin (FC) immunoassays, Liaison® Calprotectin (Diasorin) on Liaison® XL and fCAL™ turbo (Bühlmann laboratories AG) on Cobas C501 (Roche Diagnostics), and compared it with our established Bühlmann ELISA method. METHODS: Our study comprised 229 consecutive patients with clinical suspicion of inflammatory bowel disease (IBD). RESULTS: All assay related stool extraction procedures showed excellent correlation with the established method, but the new stool extraction devices tend to give higher results as compared with stool weight methods. Both automated assays demonstrated good performance in terms of precision (CVt≤8.1%), accuracy (bias≤6.7%) and total error (≤16.4%). Method comparison with established enzyme linked immunosorbent assay (ELISA) showed good correlation (rs>0.925), but regression analysis showed significant proportional differences. Diagnostic performance characteristics with regard to diagnosis of IBD were good and in line with other reports. In addition, we were able to show that optimization of manufacturer's cut-off and moreover, the introduction of a gray zone resulted in a significant increase of post-test probability. CONCLUSIONS: In conclusion, the newly developed stool extraction device protocols showed acceptable and comparable performance to the stool weight method. Overall, the automated Liaison® Calprotectin and fCAL™ turbo assay showed good analytical and diagnostic performance for detection of IBD.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. De Sloovere MMW, De Smet D, Baert FJ, et al. Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel disease. Clin Chem Lab Med. 2017. PMID: 28076305. doi:10.1515/cclm-2016-0796

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。